1-Methanesulfonyl-2-imidazolidinone

We are 1-Methanesulfonyl-2-imidazolidinone CAS:41730-79-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:   1-Methanesulfonyl-2-imidazolidinone
CAS.NO:  41730-79-4
Synonyms:
1-methylsulfonylimidazolidin-2-one
1-(Methylsulfonyl)-2-imidazolidinone
2-Imidazolidinone, 1-(methylsulfonyl)-

Molecular Formula: C4H8N2O3S
Molecular Weight:  164.18300

Physical and Chemical Properties:
Density: 1.52 g/cm3
Boiling point: /
Melting point: 188-190ºC
Flash point: /
Refractive index:1.561

Specification:
Appearance: White crystalline powder
Purity:≥99.0%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Intermediates of Mezlocillin sodium CAS:59798-30-0.

 1-Methanesulfonyl-2-imidazolidinone


Related News: In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .(S)-Methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hydroxypropyl)benzoate However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.HC Blue 14 However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.2-nitro-5-(trifluoromethoxy)aniline CAS:2267-22-3 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.

Related Products
Product Name
6-Bromohexanoyl chloride View Details
4-Methoxyphenylboronic acid View Details
Acetyl Tetrapeptide-9 View Details
5-(2-hydroxyethyl)-4-methylthiazole manufacturer 1,5-Pentanedithiol manufacturer 4-(1-Methyl-5-nitro-1H-benzimidazol-2-yl)butanoic acid manufacturer Lithium tetrakis(pentafluorophenyl)borate ethyl etherate manufacturer 2,2-Diethoxyacetophenone manufacturer